2026-01-13 - Analysis Report
## Company Overview
Intuitive Surgical Inc. is a medical device company that designs, manufactures, and markets robotic-assisted surgical systems.

### Comparison with S&P 500
- **Rate**: 81.96%
- **Rate_vs**: 94.34%
- **Divergence**: -12.38% (simply the difference in cumulative return on the last day of the data)

## Technical Analysis

### Moving Averages
* **5-day SMA**: $585.84
* **20-day SMA**: $571.59
* **60-day SMA**: $554.61

### Recent Stock Price Fluctuation
The stock price has decreased by $2.3 in the last market session.

## Indicator Analysis

### Market Risk Indicator
The Market Risk Indicator (MRI) is at 0.80, indicating a Medium Investment.

### RSI & PPO
* **RSI**: 50.17
* **PPO**: -0.01

### Hybrid Signal & Expectations
* **Buy (Cash 0%)**: No cash investment currently recommended
* **Risk Level**: Medium (MRI 0.80)
* **Recent (20 days) relative divergence change**: improving
* **7-day Rank change**: rank up
* **7-day Dynamic Expected Return change**: worsening
* **Expected Return**: 3.80% of the investment

## Recent News & Significant Events
- Is Intuitive Surgical (ISRG) Still Priced Fairly After Its Strong Multi-Year Share Price Run? - Yahoo Finance
- Is It Too Late To Consider Intuitive Surgical (ISRG) After Strong Multi Year Share Gains? - simplywall.st
- Is ISRG Stock Still A Buy At $600? - Forbes
- ISRG Intuitive Surgical (NASDAQ) pre-market $566.38 Jan 2026: AI catalysts ahead - Meyka
- How Intuitive Surgical Stock Gained 40% - Trefis
- ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now? - Zacks Investment Research

## Analyst Opinions
Analyst Consensus:
- **Key**: Buy
- **Mean (1=StrongBuy~5=Sell)**: 2.06 (~Buy)
- **Opinions**: 29
- **Target Price (avg/high/low)**: 608.26 / 740.00 / 378.00 

## Earnings Analysis (quarterly data)

| Date       | EPS | Revenue        |
|------------|-----|----------------|
| 2025-10-22 | 1.98 | $2.51B         |
| 2025-07-23 | 1.84 | $2.44B         |
| 2025-04-23 | 1.95 | $2.25B         |
| 2024-10-18 | 1.59 | $2.04B         |
| 2025-10-22 | 1.59 | $2.04B         |

## Financial Information

### Revenue and Profitability
| Quarter        | Revenue  | Profit Margin |
|----------------|----------|---------------|
| 2025-09-30     | $2.51B   | 66.36%        |
| 2025-06-30     | $2.44B   | 66.31%        |
| 2025-03-31     | $2.25B   | 64.69%        |
| 2024-12-31     | $2.41B   | 68.04%        |
| 2024-09-30     | $2.04B   | 67.41%        |

### Capital and Profitability
| Quarter        | Equity   | ROE     |
|----------------|----------|---------|
| 2025-09-30     | $16.93B  | 4.16%   |
| 2025-06-30     | $17.85B  | 3.69%   |
| 2025-03-31     | $17.11B  | 4.08%   |
| 2024-12-31     | $16.43B  | 4.17%   |
| 2024-09-30     | $15.58B  | 3.63%   |

## Comprehensive Analysis
- The cumulative return of ISRG is 81.96%, while the S&P 500 return is at 94.34%.
- The divergence in cumulative return is -12.38%.
- The 5-day SMA is $585.84, 20-day SMA is $571.59, and 60-day SMA is $554.61.
- The stock price has decreased by $2.3 in the last market session.
- The Market Risk Indicator is at 0.80, indicating a Medium Investment.
- The RSI is at 50.17, and PPO is at -0.01.
- The Expected Return is at 3.80%.
- The company has a strong growth history with a few recent negative quarterly results.
- The revenue and profit margin have been steadily increasing over the years.
- The equity and ROE have also been in positive growth.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.